This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Messas, E. Articles by Levine, R. A. Search for Related Content PubMed PubMed Citation Articles by Messas, E. Articles by Levine, R. A.

(Circulation. 2003;108:II-111.)
© 2003 American Heart Association, Inc.

Surgery for Valvular Heart Disease

Efficacy of Chordal Cutting to Relieve Chronic Persistent Ischemic Mitral Regurgitation

Emmanuel Messas, MD, MSc; Bruno Pouzet, MD; Bernard Touchot, MD; J. Luis Guerrero, BS; Gus J. Vlahakes, MD; Michel Desnos, MD; Philippe Menasché, MD, PhD; Albert Hagège, MD, PhD; Robert A. Levine, MD

From the Faculté de Médecine Necker-Enfants Malades, INSERM EMI-0016, Ecole de Chirurgie, Assistance Publique - Hôpitaux de Paris, Service de Cardiologie 1 et de Chirurgie Cardio -Vasculaire, Hôpital Européen Georges Pompidou, Paris, France; Cardiac Ultrasound Laboratory and Surgical Cardiovascular Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Correspondence to Robert A. Levine, M.D., Massachusetts General Hospital, Cardiac Ultrasound Lab, VBK508, Boston, MA 02114-3698. Phone: 617-724-1995; Fax: 617-726-8383; E-mail: rlevine{at}partners.org

Background— Mitral regurgitation (MR) conveys adverse prognosis in ischemic heart disease. Leaflet closure is restricted by tethering to displaced papillary muscles, and is, therefore, incompletely treated by annular reduction. In an acute ischemic model, we reduced such MR by cutting a limited number of critically positioned chordae to the leaflet base that most restrict closure but are not required to prevent prolapse. Whether this is effective without prolapse, recurrent MR, or left ventricular (LV) failure in chronic persistent ischemic MR, despite greater LV remodeling, remains to be established. Therefore, we studied 7 sheep with chronic inferobasal infarcts known to produce progressive MR over 2 months. In all of those sheep, after a mean of 4.1 months, the 2 central basal (intermediate) chordae were cut at the chronic ischemic MR stage. 3-Dimensional echo quantified MR, LV function, and valve geometry. Five other sheep were followed for a mean of 7.8±1.2 months after inferobasal infarction with chordal cutting.

Results— All 7 of the sheep with chronic ischemic MR (increased from 1.4±0.4 to 11.1±0.5 mL/beat, regurgitant fraction=39.0±4.2%, P<0.0001) showed anterior leaflet angulation at the basal chord insertion. Although end-systolic volume had doubled, cutting the 2 central basal chordae significantly decreased the MR to baseline (P<0.0001) without prolapse or decline in EF (41.1±1.5% to 42.6±1.6%, P=not significant [NS]). The five sheep with long-term follow-up showed no prolapse or MR, and no significant post-infarct decrease in LV ejection fraction (EF; 38.9±2.4% to 41.4±1.2%, P=NS).

Conclusion— Cutting a minimum number of basal (intermediate) chordae can improve coaptation and reduce chronic persistent ischemic MR without impairing LVEF. No adverse effects were noted long-term after chordal cutting at the time of infarction.

Key Words: mitral valve • regurgitation • remodeling • echocardiography

This article has been cited by other articles:

				M. V. Badiwala, S. Verma, and V. Rao Surgical Management of Ischemic Mitral Regurgitation Circulation, September 29, 2009; 120(13): 1287 - 1293. [Full Text] [PDF]

				R. M. Bolman III Have We Found the Surgical Solution for Ischemic Mitral Regurgitation? Circulation, June 2, 2009; 119(21): 2755 - 2757. [Full Text] [PDF]